HIV/AIDS Patient Advocacy Organization Incensed by Gilead’s 340B Descovy Price Hikes

Gilead Sciences’ refusal to provide Medicare 340B discounts for HIV drugs has drawn significant ire from HIV/AIDS patient advocacy organizations. The AIDS Healthcare Foundation (AHF) said that the pharma giant has spiked the price of its HIV drug Descovy for providers and pharmacies that deliver care to underserved communities. Gilead claims its HIV drugs do not qualify for its Contract Pharmacy Integrity Initiative.

According to Ben Adams, “To protest, AHF is hosting a weeklong, twice-daily series of protests targeting Gilead’s drug pricing and policies. The protesters, who have repurposed Gilead’s logo as “Greediad,” will start protesting each day in the morning and afternoon in front of the drugmaker’s headquarters in the Bay Area in California. A larger theatrical protest with costumes—a $1 million dollar bill, pigs’ heads and snouts, advocates dressed as burglars with money bags slung over their shoulders—is also set for this week.”

To read more, click here.

(Source: Fierce Pharma, October 26^th, 2022)